Document is current
Any future updates will be listed below
-
Authors
Santofimia-Castaño, Patricia https://orcid.org/0000-0003-2506-5567
Fraunhoffer, Nicolas
Liu, Xi
Bessone, Ivan Fernandez
di Magliano, Marina Pasca
Audebert, Stephane https://orcid.org/0000-0002-9409-2588
Camoin, Luc https://orcid.org/0000-0002-1230-4787
Estaras, Matias
Brenière, Manon
Modesti, Mauro https://orcid.org/0000-0002-4964-331X
Lomberk, Gwen https://orcid.org/0000-0001-5463-789X
Urrutia, Raul
Soubeyran, Philippe https://orcid.org/0000-0002-5876-3217
Neira, Jose Luis https://orcid.org/0000-0002-4933-0428
Iovanna, Juan https://orcid.org/0000-0003-1822-2237
-
Funding
Funding for this research was provided by:
La Ligue contre le Cancer (0021)
La Ligue contre le Cancer (0019)
Institut National Du Cancer (2020-098)
Fondation ARC pour la Recherche sur le Cancer (015)
Comunidad Valenciana (CIAICO 2021/0135)
Institut National de la Santé et de la Recherche Médicale (1068)
HHS | NIH | All of Us Research Program (R01DK052913)
- License Information
-
More Information
Article History
Received: 18 October 2023
Revised: 22 January 2024
Accepted: 25 January 2024
First Online: 15 February 2024
Disclosure and competing interests statement
: JI is co-founder of PanCa Therapeutics and PredictingMed. The other authors declare no competing interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.
